Canada markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.2900-0.0500 (-2.14%)
At close: 04:00PM EDT
2.3300 +0.04 (+1.75%)
After hours: 06:22PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts2222
Avg. Estimate-1.69-1.34-6.32-5.54
Low Estimate-2.04-1.66-7.15-6.96
High Estimate-1.35-1.02-5.49-4.13
Year Ago EPS-6.6-7.35-26.75-6.32
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts1121
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago Sales373k16k420kN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History2023-06-292023-09-292023-12-302024-03-30
EPS Est.-7.55-5.45-5.89-4.74
EPS Actual-6.6-7.35-6.23-2.27
Difference0.95-1.9-0.342.47
Surprise %12.60%-34.90%-5.80%52.10%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate-1.69-1.34-6.32-5.54
7 Days Ago-2.39-2.11-9.43-4.13
30 Days Ago-3.44-3.2-13.38-24.37
60 Days Ago-5.98-6.03-15.67-24.37
90 Days Ago-5.98-6.03-15.67-24.37
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days111N/A
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCYCCIndustrySector(s)S&P 500
Current Qtr.74.40%N/AN/AN/A
Next Qtr.81.80%N/AN/AN/A
Current Year76.40%N/AN/AN/A
Next Year12.30%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A